PARATI, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 61.862
EU - Europa 26.510
AS - Asia 16.738
SA - Sud America 1.502
AF - Africa 151
OC - Oceania 87
Continente sconosciuto - Info sul continente non disponibili 44
Totale 106.894
Nazione #
US - Stati Uniti d'America 60.906
SG - Singapore 6.733
CN - Cina 4.544
RU - Federazione Russa 4.370
IT - Italia 4.206
SE - Svezia 4.062
IE - Irlanda 4.055
DE - Germania 3.677
HK - Hong Kong 3.307
UA - Ucraina 2.289
GB - Regno Unito 1.287
BR - Brasile 1.168
CA - Canada 824
FI - Finlandia 683
VN - Vietnam 538
ID - Indonesia 479
FR - Francia 422
AT - Austria 325
NL - Olanda 289
IN - India 264
TR - Turchia 230
DK - Danimarca 200
BE - Belgio 126
JP - Giappone 104
ES - Italia 77
AU - Australia 72
MX - Messico 72
KR - Corea 71
IR - Iran 66
PE - Perù 64
CL - Cile 58
CZ - Repubblica Ceca 58
AR - Argentina 56
PL - Polonia 56
RO - Romania 50
EC - Ecuador 48
CH - Svizzera 45
PT - Portogallo 44
CO - Colombia 43
BD - Bangladesh 39
ZA - Sudafrica 37
TW - Taiwan 34
TH - Thailandia 33
BG - Bulgaria 28
EU - Europa 28
VE - Venezuela 28
PK - Pakistan 27
AE - Emirati Arabi Uniti 26
IQ - Iraq 25
UZ - Uzbekistan 25
HU - Ungheria 24
EG - Egitto 23
GR - Grecia 23
PH - Filippine 21
BO - Bolivia 19
NO - Norvegia 18
SA - Arabia Saudita 18
IL - Israele 16
MA - Marocco 16
GE - Georgia 15
AL - Albania 14
LV - Lettonia 14
AM - Armenia 13
AZ - Azerbaigian 13
KZ - Kazakistan 13
MY - Malesia 13
NZ - Nuova Zelanda 13
CR - Costa Rica 12
JO - Giordania 12
KG - Kirghizistan 12
TN - Tunisia 12
KE - Kenya 11
LK - Sri Lanka 11
LT - Lituania 11
NG - Nigeria 11
A2 - ???statistics.table.value.countryCode.A2??? 10
BY - Bielorussia 9
NP - Nepal 9
PA - Panama 9
DZ - Algeria 8
PY - Paraguay 8
RS - Serbia 8
SK - Slovacchia (Repubblica Slovacca) 8
SC - Seychelles 7
BB - Barbados 6
DO - Repubblica Dominicana 6
GT - Guatemala 6
HR - Croazia 6
JM - Giamaica 6
MD - Moldavia 6
UY - Uruguay 6
CU - Cuba 5
OM - Oman 5
EE - Estonia 4
GH - Ghana 4
SI - Slovenia 4
A1 - Anonimo 3
CY - Cipro 3
HN - Honduras 3
KW - Kuwait 3
Totale 106.828
Città #
Ann Arbor 10.712
Fairfield 6.278
Woodbridge 4.686
Singapore 4.485
Dublin 3.869
Chandler 3.818
Houston 3.708
Hong Kong 3.277
Ashburn 3.257
Wilmington 2.971
Frankfurt am Main 2.725
Jacksonville 2.604
Seattle 2.327
Cambridge 2.082
Dearborn 2.041
New York 1.837
Santa Clara 1.751
Princeton 1.739
Milan 1.180
Lawrence 833
Nanjing 794
Altamura 785
Beijing 597
San Diego 501
Shanghai 452
Jakarta 438
Lachine 375
Dong Ket 303
Boardman 286
Moscow 273
Hangzhou 260
Guangzhou 250
Nanchang 243
Shenyang 239
Vienna 238
Andover 235
Council Bluffs 219
Helsinki 209
Toronto 205
Hebei 180
London 174
Jiaxing 147
Norwalk 147
Ottawa 145
Tianjin 144
Nuremberg 143
Changsha 129
Los Angeles 125
Falls Church 118
Brussels 113
Jinan 113
Rome 109
São Paulo 95
Mountain View 86
Huizen 85
Lappeenranta 82
Zhengzhou 80
Hefei 77
Fremont 76
Kunming 72
Washington 65
Chicago 64
Detroit 63
Dallas 60
Ningbo 55
Phoenix 51
Belo Horizonte 47
Pune 44
Munich 43
Redmond 43
Saint Petersburg 43
Taizhou 43
Edmonton 42
Perugia 42
San Mateo 42
Kilburn 40
Bologna 39
Amsterdam 35
Rio de Janeiro 34
Turin 34
Brno 31
Sacramento 31
Wuhan 30
Tokyo 29
Fuzhou 28
Groningen 28
Lima 28
Naples 28
Chiswick 27
Kiev 26
University Park 26
Clearwater 25
Bergamo 24
Berlin 24
Bonndorf 24
Brasília 24
Kraków 24
Leawood 24
Santiago 24
Cinisello Balsamo 23
Totale 76.979
Nome #
Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: A randomized clinical trial 441
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 416
May Measurement Month 2017: an analysis of blood pressure screening results worldwide 405
Blood pressure and high altitude: physiological response and clinical management [Presión arterial y altitud: respuestas fisiológicas y manejo clínico] 379
Endothelin-1/nitric oxide balance and HOMA index in children with excess weight and hypertension: a pathophysiological model of hypertension 366
The impact of systolic and diastolic blood pressure variability on mortality is age dependent: Data from the Dublin Outcome Study 352
Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young 331
Effect of continuous positive airway pressure in hypertensive patients with obstructive sleep apnea and high urinary metanephrines 312
Nation-wide hypertension screening in Italy: data from May Measurements Month 2017-Europe 306
Aldosterone-To-renin ratio depends on age and sex in children attending a clinic for cardiovascular risk assessment 297
Comprehensive effects of left ventricular assist device speed changes on alveolar gas exchange, sleep ventilatory pattern, and exercise performance 290
Impact of obstructive sleep apnea on cardiac organ damage in patients with acute ischemic stroke 289
Nomograms to identify elevated blood pressure values and left ventricular hypertrophy in a paediatric population: American Academy of Pediatrics Clinical Practice vs. Fourth Report/European Society of Hypertension Guidelines 289
Calcium antagonists and neural control of circulation in essential hypertension 277
Effects of acute exposure to moderate altitude on blood pressure and sleep breathing patterns 273
Changes in 24 hour blood pressure and in cardiac and vascular structure in normotensive subjects with parental hypertension 268
Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate 266
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension 259
Morning blood pressure surge: pathophysiology, clinical relevance and therapeutic aspects 258
An ICT and mobile health integrated approach to optimize patients' education on hypertension and its management by physicians: The Patients Optimal Strategy of Treatment(POST) pilot study 257
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 253
Transthoracic bioimpedance and bnp assessment for prognostic stratification of outpatients with chronic systolic heart failure. 250
Home blood pressure telemonitoring improves hypertension control in general practice. the TeleBPCare study 249
Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: A joint statement by the european society of cardiology, the council on hypertension of the european society of cardiology, the european society of hypertension, the international society of mountain medicine, the Italian society of hypertension and the Italian society of mountain medicine 248
European society of hypertension guidelines for blood pressure monitoring at home: A summary report of the second international consensus conference on home blood pressure monitoring 247
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 245
Improvement of functional capacity in sacubitril-valsartan treated patients assessed by cardiopulmonary exercise test 239
Blood pressure variability and obstructive sleep apnea. A question of phenotype? 236
Cap. 8: Cuore e malattie sistemiche 233
Effects of lifestyle modifications on elevated blood pressure and excess weight in a population of Italian children and adolescents 231
Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension 230
Role of T1 mapping as a complementary tool to T2* for non-invasive cardiac iron overload assessment 228
Different effects of antihypertensive treatment on office and ambulatory blood pressure: Ameta-analysis 228
Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans 228
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings 225
Prognostic role of β-blocker selectivity and dosage regimens in heart failure patients. Insights from the MECKI score database 224
Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years 223
Pulsed intravenous methylprednisolone combined with oral steroids as a treatment for poorly responsive type 2 amiodarone-induced thyrotoxicosis 223
Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol 222
Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: Meta-analysis of randomised controlled trials 221
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 221
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 219
Noninvasive Estimation of Aortic Stiffness Through Different Approaches: Comparison with Intra-Aortic Recordings 219
Randomized Controlled Trials of Blood Pressure Lowering in Hypertension: A Critical Reappraisal 214
Influence of cardiopulmonary receptors on the bradycardiac responses to carotid baroreceptor stimulation in man 214
Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol 213
Blood pressure response to labetalol in twice and three times daily administration during a 24‐hour period 212
Modification of arterial baroreflexes by captopril in essential hypertension 211
Evaluation of a slow-release clonidine preparation by direct continuous blood pressure recording in essential hypertensive patients 209
High altitude exposure of three weeks duration increases lung diffusing capacity in humans 209
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 209
Hemodynamic and Autonomic Response to Different Salt Intakes in Normotensive Individuals 208
Validation of the Somnotouch-NIBP noninvasive continuous blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010 207
Mechanisms of antihypertensive action of beta-adrenergic blocking drugs: evidence against potentiation of baroreflexes 206
Heart failure and anemia: Effects on prognostic variables 205
Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension 204
Control of blood pressure by carotid sinus baroreceptors in human beings 202
[Are plasma catecholamine levels capable of reflecting even small variations in sympathetic activity?] 198
Circulating factors are involved in hypoxia-induced hepcidin suppression 197
Predicting Depression from Illness Severity in Cardiovascular Disease Patients: Self-efficacy Beliefs, Illness Perception, and Perceived Social Support as Mediators 197
Intra-aortic balloon pump for treatment of refractory ventricular tachycardia in Tako-Tsubo cardiomyopathy: A case report 196
Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: A meta-analysis 196
A randomized and controlled study of noninvasive hemodynamicmonitoring as a guide to drug treatment of uncontrolled hypertensive patients 195
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 195
Control of circulation by arterial baroreceptors and cardiopulmonary receptors in hypertension 195
The Added Value of 3-Dimensional Echocardiography to Understand the Pathophysiology of Functional Tricuspid Regurgitation 195
Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude 194
Effects of device-guided slow breathing training on exercise capacity, cardiac function, and respiratory patterns during sleep in male and female patients with chronic heart failure 194
Obstructive sleep apnoea treatment and blood pressure: Which phenotypes predict a response? A systematic review and meta-analysis 193
Dynamic adaptation of cardiac baroreflex sensitivity to prolonged exposure to microgravity: data from 16-day spaceflight 192
Blood Pressure Response to Exercise in Hypertensive Subjects Exposed to High Altitude and Treatment Effects 192
Multiparametric prognostic scores in chronic heart failure with reduced ejection fraction: a long-term comparison 192
Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study 191
Effects of selective and nonselective beta-blockade on 24-h ambulatory blood pressure under hypobaric hypoxia at altitude 190
Effects of beta-blockade on exercise performance at high altitude: a randomized, placebo-controlled trial comparing the efficacy of nebivolol versus carvedilol in healthy subjects 190
Prognostic value of baroreflex sensitivity in heart failure. A 2018 reappraisal 190
Alerting reaction and rise in blood pressure during measurement by physician and nurse 190
Clinical and psychological telemonitoring and telecare of high risk heart failure patients 190
Vascular Health Assessment of The Hypertensive Patients (VASOTENS) Registry: Study Protocol of an International, Web-Based Telemonitoring Registry for Ambulatory Blood Pressure and Arterial Stiffness 189
Prevalence of hypertension and cardiovascular risk factors in chinese migrating to Milan as compared to a northern italian population 189
Recommendations and Practical Guidance for performing and reporting validation studies according to the Universal Standard for the validation of blood pressure measuring devices by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) 189
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 189
Evaluation of relationship between cardio-ankle vascular index and 24h ambulatory blood pressure variables 188
Intermittent levosimendan infusions in advanced heart failure: a real world experience 188
MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: A randomised controlled trial protocol 188
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: Rationale for further study on blood pressure targets of antihypertensive treatment after stroke 187
Effects of hypobaric hypoxia exposure at high altitude on left ventricular twist in healthy subjects: Data from HIGHCARE study on Mount Everest 187
Reduction of 24-h blood pressure variability in extreme obese patients 10 days and 6 months after bariatric surgery depending on pre-existing hypertension 185
[Direct and continuous recording of arterial pressure in the diagnosis of pheochromocytoma] 184
Periodic limb movements during sleep and blood pressure changes in sleep apnoea: Data from the European Sleep Apnoea Database 184
Role of acetazolamide and telmisartan/nifedipine-GITS combination in antagonizing the blood pressure rise induced by high altitude exposure 183
Short-Term Repeatability of Noninvasive Aortic Pulse Wave Velocity Assessment: Comparison between Methods and Devices 183
Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure 182
Isolated systolic hypertension in the young: A position paper endorsed by the European Society of Hypertension 182
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 182
Prolonged QRS associated with left bundle branch conduction defect is a prognostic red flag in asymptomatic patients at risk for heart failure (ACCF/AHA stages A and B): Insights from the DAVID-Berg study 181
High-altitude hypoxia and periodic breathing during sleep: gender related differences 180
Mechanisms of obesity-induced hypertension 180
Correlation between pulmonary artery pressure and thoracic impedance: Insights from daily monitoring through an implanted device in chronic heart failure 180
Pulmonary congestion at rest and abnormal ventilation during exercise in chronic systolic heart failure 179
Totale 22.717
Categoria #
all - tutte 453.621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 453.621


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.513 0 0 0 0 0 0 0 0 0 1.005 1.074 434
2020/202115.317 967 759 1.600 1.602 1.140 1.364 1.581 1.547 1.371 1.428 737 1.221
2021/202211.977 750 1.116 1.755 955 812 626 659 684 634 798 1.160 2.028
2022/202316.288 2.161 4.384 1.536 1.313 1.067 2.717 208 845 1.064 196 448 349
2023/202412.193 352 463 433 498 1.787 3.172 2.305 306 1.112 224 207 1.334
2024/202520.693 1.931 3.853 1.525 1.417 2.753 1.227 1.740 1.263 3.581 1.403 0 0
Totale 110.656